These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16216892)

  • 1. The shortage of drugs to treat pediatric malignancies: why does this happen?
    Kline NE
    J Pediatr Oncol Nurs; 2005; 22(6):303-4. PubMed ID: 16216892
    [No Abstract]   [Full Text] [Related]  

  • 2. The shortage of essential chemotherapy drugs in the United States.
    Gatesman ML; Smith TJ
    N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
    [No Abstract]   [Full Text] [Related]  

  • 3. Shortages of essential medications for children with cancer in Colombia.
    Bustamante LU; Acosta AC; Perico DE; Grynszpancholc E
    Lancet Oncol; 2021 Oct; 22(10):1343-1345. PubMed ID: 34560005
    [No Abstract]   [Full Text] [Related]  

  • 4. The silent victims of the US embargo against Iran.
    Ghalibafian M; Hemmati S; Bouffet E
    Lancet Oncol; 2018 Nov; 19(11):e580. PubMed ID: 30507483
    [No Abstract]   [Full Text] [Related]  

  • 5. An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood Cancer.
    Unguru Y; Fernandez CV; Bernhardt B; Berg S; Pyke-Grimm K; Woodman C; Joffe S
    J Natl Cancer Inst; 2016 Jun; 108(6):djv392. PubMed ID: 26825103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hospital network in pediatric oncology].
    Doz F
    Arch Pediatr; 2006 Jun; 13(6):635-7. PubMed ID: 16697587
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer.
    Unguru Y; Bernhardt MB; Berg SL; Johnson LM; Pyke-Grimm K; Woodman C; Fernandez CV
    JAMA Pediatr; 2019 May; 173(5):477-484. PubMed ID: 30830204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing drugs for pediatric malignancies.
    Adamson PC
    Clin Adv Hematol Oncol; 2013 Apr; 11(4):227-9. PubMed ID: 23604239
    [No Abstract]   [Full Text] [Related]  

  • 9. Availability of Essential Medicines for Pediatric Oncology in Armenia.
    Simonyan T; Papyan R; Danielyan S; Sargsyan L; Grigoryan V; Topchyan H; Azaryan A; Tananyan A; Muradyan A; Tamamyan G
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):991-994. PubMed ID: 31030465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential medicines for children with cancer.
    Barr RD
    Pediatr Blood Cancer; 2013 May; 60(5):888. PubMed ID: 23255433
    [No Abstract]   [Full Text] [Related]  

  • 11. The lawsuits to antineoplastic drugs: the tip of an iceberg?
    Vidal TJ; Moraes EL; Retto MPF; Silva MJSD
    Cien Saude Colet; 2017 Aug; 22(8):2539-2548. PubMed ID: 28793070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compulsory licensing issues and trends in Asia.
    Rungpry SK
    Pharm Pat Anal; 2013 Nov; 2(6):681-3. PubMed ID: 24237231
    [No Abstract]   [Full Text] [Related]  

  • 13. Shortage of cancer drugs in Mexico.
    Das M
    Lancet Oncol; 2021 Sep; 22(9):1216. PubMed ID: 34332658
    [No Abstract]   [Full Text] [Related]  

  • 14. Framework for tackling paediatric chemotherapy drug shortages.
    Tanday S
    Lancet Oncol; 2016 Mar; 17(3):e93. PubMed ID: 26831287
    [No Abstract]   [Full Text] [Related]  

  • 15. [Off label drugs and pediatric hematology-oncology practices].
    Le Guyader N; Pouliquen AL; Benoit G; Leverger G
    Arch Pediatr; 2006 Sep; 13(9):1267-8. PubMed ID: 16814531
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicines for pediatric oncology: can we overcome the failure to deliver?
    Saint-Raymond A; Herold R
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):493-5. PubMed ID: 23121268
    [No Abstract]   [Full Text] [Related]  

  • 17. European governments are failing cancer patients.
    Eur J Cancer Care (Engl); 2001 Dec; 10(4):230. PubMed ID: 11806672
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.
    Bauters T; Claus BO; Norga K; Huys I; Simoens S; Laureys G
    J Oncol Pharm Pract; 2016 Dec; 22(6):766-770. PubMed ID: 26447099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differences in the access to new anticancer drugs?].
    Norderhaug I
    Tidsskr Nor Laegeforen; 2007 Feb; 127(4):460. PubMed ID: 17304285
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer drugs. Weighing the risks and benefits.
    Bren L
    FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.